Tech Compression Dragged Oracle Stock to $175, but Its Unbelievable $638 Billion AI Backlog Makes It an Automatic Buy

Oracle’s Q4 showed a $638 billion RPO backlog, with cloud infrastructure revenue up 93% year over year to $5.79 billion and management lifting FY2027 revenue guidance to $90 billion and non-GAAP EPS to $8.05. The stock still faces heavy cash burn, with FY26 free cash flow at -$23.69 billion against $55.66 billion of capex and a planned ~$40 billion capital raise in FY27, but analysts remain constructive with a $252.64 consensus target versus the current $175.07 share price. Mizuho reiterated Outperform with a $320 target, suggesting upside if cloud growth stays within the guided range.

Analysis

The key market mistake is treating Oracle as a generic software multiple compression story when the underlying asset is shifting toward contracted infrastructure economics. The backlog quality matters more than the headline size: a meaningful slice is pre-funded or customer-supplied, which reduces the usual hyperscaler capex burden and should steepen future free-cash-flow conversion once the buildout crosses the peak-investment phase. That makes the relevant comparison not to legacy software peers, but to infrastructure-heavy AI winners where valuation resets tend to happen late, not early.

Second-order beneficiaries include the GPU and networking ecosystem, especially firms exposed to incremental AI cluster deployments, because Oracle’s ability to turn backlog into revenue depends on rapid data-center scaling rather than software-seat growth. Amazon is the main competitive cross-check: if OCI keeps taking training/inference share, the market will eventually price AWS not just as the incumbent, but as the benchmark Oracle must match on reliability and delivery cadence. That should keep hyperscaler spending elevated even if some investors hoped for an AI capex pause, which is constructive for suppliers but pressure on software margin narratives broadly.

The bear case is less about demand and more about timing mismatch: equity dilution, debt issuance, and negative FCF can suppress the stock for quarters even if the strategic thesis is right. The cleanest reversal trigger is not a perfect year-end model, but a sequence of quarters where cloud growth stays inside guide and the company demonstrates that backlog conversion is outpacing incremental financing needs. If that happens, consensus will likely move faster on FY28 than FY27, and the rerating could be abrupt because the market is currently anchoring to cash burn instead of contracted revenue visibility.

Contrarianly, the move looks underdone rather than overdone if investors are willing to look through the next 2-3 quarters. At this price, the market is implicitly discounting either a severe execution miss or a financing event that destroys the equity story; if neither occurs, the valuation gap to the target set is too wide to ignore. The higher-probability surprise is not that Oracle becomes the next pure software compounder, but that it becomes a quasi-infrastructure asset with software-like earnings leverage once the heavy buildout period rolls off.

Key Decisions for Investors

• Long ORCL common into the next quarterly print; use a 3-6 month horizon and size for volatility because the stock can stay range-bound while FCF remains negative, but the risk/reward improves materially if cloud growth prints inside guidance.
• Buy ORCL Jan-2026 or Jan-2027 call spreads to express upside with defined downside; target a move toward the low-$200s if the market starts capitalizing backlog conversion rather than current cash burn.
• Pair long ORCL / short a basket of high-multiple legacy software names that lack contracted AI infrastructure revenue; this isolates the thesis that infrastructure-backed growth should outperform seat-based software compression.
• If already long, hedge financing-risk with a partial short-dated put spread through the next earnings cycle; the main near-term failure mode is not thesis breakage but a dilution-driven drawdown.
• Add AMZN as a secondary long only on weakness if OCI momentum forces AWS to sustain elevated AI capex; the trade is a relative winner from ongoing AI infrastructure investment, not a direct Oracle substitute.